| 1 |
ClinicalTrials.gov (NCT05446740) A Phase 1 Randomized, Observer-blind, Dose-escalation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of an mRNA-based Monovalent Influenza Vaccine Candidate in Healthy Younger and Older Adults. U.S.National Institutes of Health.
|
